Non-Hodgkin's Lymphoma, Relapsed

Also known as: Relapsed Non-Hodgkin's Lymphoma (NHL) / Relapsed Non-Hodgkin's Lymphoma / Relapsed Non-Hodgkin-Lymphoma / Relapsed Non-Hodgkin Lymphoma / Relapsed Non Hodgkin Lymphoma

DrugDrug NameDrug Description
DB00563MethotrexateAn antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis.
DB06193PixantroneAn antineoplastic agent use to treat patients with relapsed or refractory aggressive Non-Hodgkin B-cell Lymphomas (NHL).
DrugDrug NameTargetType
DB00563MethotrexateDihydrofolate reductasetarget
DB00563MethotrexateAldehyde oxidaseenzyme
DB00563MethotrexateMethylenetetrahydrofolate reductaseenzyme
DB00563MethotrexateSerum albumincarrier
DB00563MethotrexateCanalicular multispecific organic anion transporter 2transporter
DB00563MethotrexateMultidrug resistance-associated protein 4transporter
DB00563MethotrexateMultidrug resistance-associated protein 1transporter
DB00563MethotrexateSolute carrier family 22 member 6transporter
DB00563MethotrexateMultidrug resistance-associated protein 7transporter
DB00563MethotrexateSolute carrier family 22 member 8transporter
DB00563MethotrexateCanalicular multispecific organic anion transporter 1transporter
DB00563MethotrexateP-glycoprotein 1transporter
DB00563MethotrexateSolute carrier organic anion transporter family member 1A2transporter
DB00563MethotrexateMonocarboxylate transporter 1transporter
DB00563MethotrexateATP-binding cassette sub-family C member 11transporter
DB00563MethotrexateSolute carrier organic anion transporter family member 1B3transporter
DB00563MethotrexateSolute carrier family 22 member 11transporter
DB00563MethotrexateSolute carrier organic anion transporter family member 1C1transporter
DB00563MethotrexateSolute carrier organic anion transporter family member 3A1transporter
DB00563MethotrexateATP-binding cassette sub-family G member 2transporter
DB00563MethotrexateSolute carrier family 22 member 7transporter
DB00563MethotrexateSolute carrier organic anion transporter family member 1B1transporter
DB00563Methotrexate6-phosphogluconate dehydrogenase, decarboxylatingenzyme
DB00563MethotrexateProton-coupled folate transportertransporter
DB00563MethotrexateFolylpolyglutamate synthase, mitochondrialenzyme
DB00563MethotrexateGamma-glutamyl hydrolaseenzyme
DB00563MethotrexateDihydrofolate reductaseenzyme
DB00563MethotrexateThymidylate synthaseenzyme
DB00563MethotrexateBifunctional purine biosynthesis protein PURHenzyme
DB00563MethotrexateSolute carrier organic anion transporter family member 4C1transporter
DB00563MethotrexateFolate transporter 1transporter
DB00563MethotrexateFolate receptor alphatransporter
DB00563MethotrexateCytochrome P450 3A4enzyme
DB00563MethotrexateThymidylate synthasetarget
DB00563MethotrexateBifunctional purine biosynthesis protein PURHtarget
DB00563MethotrexateFolate receptor betatransporter
DB00563MethotrexateSolute carrier family 15 member 1transporter
DB00563MethotrexateProton-coupled amino acid transporter 1transporter
DB00563MethotrexateCarboxypeptidase G2enzyme
DrugDrug NamePhaseStatusCount
DB00531Cyclophosphamide0Completed1
DB00091Cyclosporine0Completed1
DB01254Dasatinib0Recruiting1
DB01073Fludarabine0Completed1
DB00688Mycophenolate mofetil0Completed1
DB09052Blinatumomab1Completed1
DB00531Cyclophosphamide1Recruiting1
DB01073Fludarabine1Recruiting1
DB16582Lisocabtagene maraleucel1Not Yet Recruiting1
DB16222Loncastuximab tesirine1Recruiting1
DB11581Venetoclax1Recruiting1
DB00041Aldesleukin1 / 2Unknown Status1
DB00958Carboplatin1 / 2Completed1
DB00531Cyclophosphamide1 / 2Completed1
DB00531Cyclophosphamide1 / 2Unknown Status1
DB00987Cytarabine1 / 2Completed1
DB01234Dexamethasone1 / 2Completed1
DB00099Filgrastim1 / 2Completed1
DB01073Fludarabine1 / 2Completed1
DB01073Fludarabine1 / 2Unknown Status1
DB00480Lenalidomide1 / 2Terminated1
DB15721Natural Killer Cell1 / 2Unknown Status1
DB09037Pembrolizumab1 / 2Terminated1
DB00073Rituximab1 / 2Completed1
DB00073Rituximab1 / 2Unknown Status1
DB11581Venetoclax1 / 2Active Not Recruiting1
DB00026Anakinra2Active Not Recruiting1
DB09312Antilymphocyte immunoglobulin (horse)2Active Not Recruiting1
DB00098Antithymocyte immunoglobulin (rabbit)2Active Not Recruiting1
DB13915Axicabtagene ciloleucel2Active Not Recruiting1
DB00928Azacitidine2Not Yet Recruiting1
DB00515Cisplatin2Not Yet Recruiting1
DB00091Cyclosporine2Active Not Recruiting1
DB01234Dexamethasone2Not Yet Recruiting1
DB00441Gemcitabine2Not Yet Recruiting1
DB00078Ibritumomab tiuxetan2Active Not Recruiting1
DB15434Mosunetuzumab2Recruiting1
DB00688Mycophenolate mofetil2Active Not Recruiting1
DB12240Polatuzumab vedotin2Recruiting1
DB00073Rituximab2Active Not Recruiting1
DB00073Rituximab2Completed1
DB00073Rituximab2Not Yet Recruiting1
DB14922Tislelizumab2Recruiting1
DB00023Asparaginase Escherichia coli3Unknown Status1
DB00515Cisplatin3Unknown Status1
DB01234Dexamethasone3Unknown Status1
DB00773Etoposide3Unknown Status1
DB00441Gemcitabine3Unknown Status1